Singla Sanju, Prabhakar Vikram, Singla Rajan Kumar
Department of Oral and Maxillofacial Surgery, Dasmesh Institute of Research and Dental Sciences, Faridkot, Punjab, India.
J Neurosci Rural Pract. 2011 Jul;2(2):150-2. doi: 10.4103/0976-3147.83580.
Trigeminal neuralgia typically involves nerves supplying teeth, jaws and face of older females. Though the etiology is usually obscure, different treatment modalities have been tried for it viz. medicinal treatment, injection alcohol, peripheral neurectomy, rhizotomy, and microvascular decompression etc. Transcutaneous electric nerve stimulation (TENS) is an emerging and promising option for management of such patients.
The present study was designed with an aim to study the efficacy of TENS in management of trigeminal neuralgia.
The study was conducted on 30 patients of trigeminal neuralgia confirmed by diagnostic nerve block. They were given bursts of TENS for 20-40 days over the path of the affected nerve and subsequently evaluated at 1 month and 3 month intervals by visual analogue scale (VAS), verbal pain scale (VPS), a functional outcome scales for main daily activities like sleep, chewing, talking, or washing face.
The results showed that, on VAS, the score decreased from 8.9 (Pre TENS) to 3.1 at 1 month and 1.3 at 3 months, and on VPS, the score decreased from 3.5 (Pre TENS) to 1.2 at 1 month and 0.3 at 3 months. Similarly, a considerable decrease in scores was seen on functional outcome scale for different activities. No side effects like irritation or redness of skin were seen in any of the patients.
Thus, TENS was found to be a safe, easily acceptable, and non-invasive outdoor patient department procedure for management of trigeminal neuralgia.
三叉神经痛通常累及供应老年女性牙齿、颌骨和面部的神经。尽管病因通常不明,但已尝试了不同的治疗方式,即药物治疗、酒精注射、周围神经切除术、神经根切断术和微血管减压术等。经皮电刺激神经疗法(TENS)是治疗此类患者的一种新兴且有前景的选择。
本研究旨在探讨TENS治疗三叉神经痛的疗效。
对30例经诊断性神经阻滞确诊的三叉神经痛患者进行了研究。在受影响神经的路径上给予TENS脉冲20 - 40天,随后每隔1个月和3个月通过视觉模拟量表(VAS)、言语疼痛量表(VPS)以及睡眠、咀嚼、说话或洗脸等主要日常活动的功能结局量表进行评估。
结果显示,在VAS上,评分从(TENS治疗前)8.9降至1个月时的3.1和3个月时的1.3;在VPS上,评分从(TENS治疗前)3.5降至1个月时的1.2和3个月时的0.3。同样,不同活动的功能结局量表评分也有显著下降。所有患者均未出现皮肤刺激或发红等副作用。
因此,TENS被发现是一种安全、易于接受且非侵入性的门诊治疗三叉神经痛的方法。